Item 4. MINE SAFETY DISCLOSURES

Not applicable.

INFORMATION ABOUT OUR EXECUTIVE OFFICERS

Executive officers of Abbott are elected annually by the Board of Directors. Each executive officer holds office until a successor has been duly elected or appointed and qualified or until the officer’s death, resignation, or removal. Vacancies may be filled at any time by the Board of Directors. Any executive officer may be removed by the Board of Directors when, in its judgment, removal would serve the best interests of Abbott.

Abbott’s executive officers, their ages as of February 20, 2026, and the dates of their first election as officers of Abbott are listed below. The executive officers’ principal occupations and employment for the past five years and the year of appointment to the earliest reported office are also shown. Unless otherwise stated, employment was by Abbott. There are no family relationships between any executive officers or directors.

Robert B. Ford, 52

2021 to present — Chairman of the Board and Chief Executive Officer, and Director.

2020 to 2021 — President and Chief Executive Officer, and Director.

Elected Corporate Officer — 2008.

Philip P. Boudreau, 53

2024 to present — Executive Vice President, Finance and Chief Financial Officer.

2023 to 2024 — Senior Vice President, Finance and Chief Financial Officer.

2020 to 2023 — Vice President, Finance and Controller.

Elected Corporate Officer — 2020.

Elizabeth C. Cushman, 56

2025 to present — Executive Vice President, General Counsel and Secretary.

2024 to 2025 — Senior Vice President, Legal.

2023 to 2024 — Vice President, Specialty Legal.

2021 to 2023 — Divisional Vice President and Associate General Counsel, Legal Regulatory and Compliance.

Elected Corporate Officer — 2023.

Lisa D. Earnhardt, 56

2023 to present — Executive Vice President and Group President, Medical Devices.

2019 to 2023 — Executive Vice President, Medical Devices.

Elected Corporate Officer — 2019.

Mary K. Moreland, 59

2019 to present — Executive Vice President, Human Resources.

Elected Corporate Officer — 2019.

Louis H. Morrone, 49

2023 to present — Executive Vice President, Core Diagnostics.

2021 to 2023 — Senior Vice President, Rapid Diagnostics.

2017 to 2021 — Vice President, Transfusion Medicine.

Elected Corporate Officer — 2017.

Daniel Salvadori, 47

2021 to present — Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products.

2017 to 2021 — Executive Vice President, Nutritional Products.

Elected Corporate Officer — 2014.

Christopher J. Scoggins, 56

2025 to present — Executive Vice President, Diabetes Care.

2023 to 2024 — Senior Vice President, Commercial Operations and Marketing, Abbott Diabetes Care.

2021 to 2023 — Vice President, Commercial Operations and Marketing, Abbott Diabetes Care.

2019 to 2021 — Senior Vice President, Rapid Diagnostics.

Elected Corporate Officer — 2015.

Eric Shroff, 54

2025 to present — Senior Vice President, Rapid and Molecular Diagnostics.

2018 to 2025 — Vice President, Abbott Point of Care.

Elected Corporate Officer — 2018.

John A. McCoy, Jr., 56

2023 to present — Vice President, Finance and Controller.

2021 to 2023 — Vice President, Treasurer.

2018 to 2021 — Divisional Vice President, Controller, Rapid Diagnostics.

Elected Corporate Officer — 2021.

PART II